Total Payments
$3,821
2024 Payments
$745.84
Companies
31
Transactions
271
Medicare Patients
6,660
Medicare Billing
$737,058
Payment Breakdown by Category
Food & Beverage$3,821 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,821 | 271 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,051 | 100 | $0 (2024) |
| Novo Nordisk Inc | $532.43 | 31 | $0 (2024) |
| ABBVIE INC. | $531.29 | 36 | $0 (2024) |
| GlaxoSmithKline, LLC. | $295.35 | 17 | $0 (2024) |
| Astellas Pharma US Inc | $251.63 | 15 | $0 (2024) |
| Merck Sharp & Dohme LLC | $107.45 | 7 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $104.90 | 8 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $100.12 | 7 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $98.58 | 7 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $79.47 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $745.84 | 57 | PFIZER INC. ($240.54) |
| 2023 | $773.89 | 59 | PFIZER INC. ($244.76) |
| 2022 | $564.51 | 37 | Novo Nordisk Inc ($164.57) |
| 2021 | $589.47 | 43 | PFIZER INC. ($264.42) |
| 2020 | $187.18 | 13 | PFIZER INC. ($52.82) |
| 2019 | $328.66 | 20 | AbbVie, Inc. ($43.58) |
| 2018 | $362.69 | 24 | PFIZER INC. ($63.65) |
| 2017 | $268.85 | 18 | GlaxoSmithKline, LLC. ($65.24) |
All Payment Transactions
271 individual payment records from CMS Open Payments — Page 11 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/25/2018 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Endocrinology | ||||||
| 01/18/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/11/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Respiratory | ||||||
| 10/12/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: RESPIRATORY | ||||||
| 10/05/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.04 | General |
| Category: Cardiovascular | ||||||
| 09/28/2017 | Pernix Therapeutics Holdings, Inc. | TREXIMET (Drug) | Food and Beverage | In-kind items and services | $10.69 | General |
| Category: NEUROLOGY | ||||||
| 09/14/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: RESPIRATORY | ||||||
| 08/10/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: RESPIRATORY | ||||||
| 07/20/2017 | Merck Sharp & Dohme Corporation | ZOSTAVAX (Biological), PNEUMOVAX 23, GARDASIL9 | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: VACCINE | ||||||
| 07/13/2017 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Immunology | ||||||
| 06/14/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/08/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/18/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.89 | General |
| Category: Cardiovascular | ||||||
| 04/13/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: RESPIRATORY | ||||||
| 04/06/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Urology | ||||||
| 03/23/2017 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Drug), ADACEL, NO PRODUCT DISCUSSED | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: VACCINES | ||||||
| 02/23/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ZOSTAVAX | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/27/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Respiratory | ||||||
| 01/19/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: RESPIRATORY | ||||||
| 01/12/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Hypertriglyceridemia | ||||||
| 01/05/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,865 | 2,217 | $283,313 | $221,081 |
| 2022 | 24 | 1,567 | 1,878 | $220,907 | $164,874 |
| 2021 | 24 | 1,651 | 2,148 | $255,530 | $190,375 |
| 2020 | 21 | 1,577 | 2,052 | $219,420 | $160,728 |
Total Patients
6,660
Total Services
8,295
Medicare Billing
$737,058
Procedure Codes
89
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 219 | 219 | $66,795 | $61,900 | 92.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 304 | 304 | $45,600 | $40,678 | 89.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 268 | 430 | $62,350 | $40,313 | 64.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 181 | 184 | $14,900 | $13,194 | 88.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 23 | 98 | $13,034 | $9,540 | 73.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 63 | 68 | $15,640 | $9,243 | 59.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 58 | 137 | $12,467 | $8,823 | 70.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 222 | 222 | $6,660 | $6,527 | 98.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 51 | 60 | $8,640 | $5,645 | 65.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 184 | 187 | $5,610 | $5,498 | 98.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 22 | 22 | $4,180 | $3,769 | 90.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 20 | 20 | $3,800 | $3,420 | 90.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 49 | $5,390 | $3,380 | 62.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 13 | $4,030 | $2,980 | 73.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 40 | 43 | $3,870 | $1,776 | 45.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $2,832 | $1,697 | 59.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 29 | 36 | $2,520 | $1,049 | 41.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Facility | 2023 | 20 | 20 | $1,700 | $788.80 | 46.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 53 | 54 | $2,700 | $566.35 | 21.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 34 | 35 | $595.00 | $294.00 | 49.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 269 | 426 | $61,770 | $41,490 | 67.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 296 | 296 | $44,400 | $40,745 | 91.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 178 | 178 | $13,350 | $12,132 | 90.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 93 | 147 | $13,286 | $8,620 | 64.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 68 | 69 | $12,213 | $7,748 | 63.4% |
About Dr. David Litt, MD
Dr. David Litt, MD is a Internal Medicine healthcare provider based in Meadowbrook, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265403240.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Litt, MD has received a total of $3,821 in payments from pharmaceutical and medical device companies, with $745.84 received in 2024. These payments were reported across 271 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,821).
As a Medicare-enrolled provider, Litt has provided services to 6,660 Medicare beneficiaries, totaling 8,295 services with total Medicare billing of $737,058. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Meadowbrook, PA
- Active Since 01/30/2006
- Last Updated 07/18/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1265403240
Products in Payments
- ELIQUIS (Drug) $673.80
- PREVNAR 20 (Biological) $266.90
- Ozempic (Drug) $209.87
- Rybelsus (Drug) $204.02
- UBRELVY (Drug) $197.50
- TRELEGY ELLIPTA (Drug) $180.58
- VRAYLAR (Drug) $148.07
- CHANTIX (Drug) $116.40
- ANORO (Drug) $102.05
- QULIPTA (Drug) $100.79
- XARELTO (Drug) $100.12
- MYRBETRIQ (Drug) $85.65
- Creon (Drug) $84.93
- XIFAXAN (Drug) $78.32
- Veozah (Drug) $70.08
- Cologuard Collection Kit (Device) $63.35
- Myrbetriq (Drug) $60.79
- ENTRESTO (Drug) $56.49
- TRUMENBA (Biological) $44.13
- NUEDEXTA (Drug) $42.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Meadowbrook
John Butler, Md, MD
Internal Medicine — Payments: $2,871
Internal Medicine $2,871
Dominick Galluzzo, Md, MD
Internal Medicine — Payments: $2,072
Internal Medicine $2,072
Dr. Leonard Khrizman, M.d, M.D
Internal Medicine — Payments: $551.55
Internal Medicine $551.55
Joseph Viknevich, M.d, M.D
Internal Medicine — Payments: $453.22
Internal Medicine $453.22
Dr. Babak Pirouz, Md, MD
Internal Medicine — Payments: $314.45
Internal Medicine $314.45
Maureen Armstrong, Do, DO
Internal Medicine — Payments: $121.36
Internal Medicine $121.36